From Wrinkle Smoother to Migraine Headache - Allergan Inc

Who would ever come up with the idea to use a wrinkle smoother to treat migraine headache?  You probably may by accident.  But to proof it to the FDA that it really works so that you can commercialize the idea?  Probably need plenty of cash and a million dollar R&D like the biotech giant Allergan Inc. (NYSE:AGN).  The biotech company received approval from FDA recently to sell Botox, a wrinkle smoother, as a migraine headache treatment.  And analyst predicts the approval could double Botox's annual sale to $2.3 billion as the result of the approval.  


Shares of AGN are traded at $70.84, near its 52 weeks high.  It's technical trend is still pointing up so the recent pull back to $66 actually provided a great buying opportunity.  The stock should continue to head back to the previous high of $74 per share.